Investors / United States / Casa Verde Capital
Casa Verde Capital
Venture capital · West Hollywood, CA, United States · North America
Casa Verde Capital is an investment fund focused on the cannabis industry, established in 2015. It invests in a select number of companies and works with portfolio companies to address operational issues across the value chain.
Invests inHealthcare & Biotech
In its own wordscannabise-commercesoftwarestaffingmarketplaceag tech
Your fit with Casa Verde Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCasa Verde Capital lists 20 checked portfolio companies on its own site and is named in 1 funding round, 1 of them as lead. Its largest themes are Healthcare & Biotech (50%), AI & Machine Learning (12%) and Consumer (8%). 57% of its companies are based in United States. It invests most often alongside Level One Fund, Fairhaven Capital and KEY Investment Partners.
Counts come from funding rounds that name Casa Verde Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Casa Verde Capital's whole history. Rounds on record name 1 company; its own site lists 20. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundCasa Verde Capital does not state its stages on its site, so only what it does is shown.
The rounds that name Casa Verde Capital do not give a stage.
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 0 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 51th | 20 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 85th | 50% in its largest sector |
| Reach | 84th | 6 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 50% | 15% |
| AI & Machine Learning | 12% | 18% |
| Consumer | 8% | 3% |
| Climate & Energy | 8% | 1% |
| Fintech | 8% | 12% |
| Media & Entertainment | 4% | 4% |
| E-commerce & Marketplaces | 4% | 6% |
| Cybersecurity | 4% | 4% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Level One Fund | 4 |
| Fairhaven Capital | 2 |
| KEY Investment Partners | 2 |
| Lerer Hippeau | 2 |
| ARTIS | 1 |
| Advancit Capital | 1 |
| Argonautic Ventures | 1 |
| Ataria | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1995%
- No longer answers00%
- Points to another company15%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Casa Verde Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Casa Verde Capital| Date | Company | Stage |
|---|---|---|
| 1 Sept 2025 | Round Led |
Round details for Casa Verde Capital
Amounts, full round histories and every co-investor in Casa Verde Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
20 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AceCann cultivates, processes, and extracts medical cannabis products for the European market | Healthcare & Biotech | Portfolio page | ||
| The company enables access to medical cannabis products for pharmacies, doctors, and patients, and also provides market access for suppliers and manufacturers. | Healthcare & Biotech | Portfolio page | ||
| Delix Therapeutics is developing novel therapeutics to address brain health challenges | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Eaze delivers cannabis products on demand | Healthcare & Biotech | Portfolio page | ||
| Endless West creates and manufactures spirits using molecular science and offers various services including bulk spirits, packaged brands, concentrates, and co-packing. | Food & AgricultureConsumer | Portfolio page | ||
| Frontier Risk provides insurance coverages tailored for the cannabis industry | FintechCybersecurity | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Green Tank Technologies produces vape hardware solutions, including cartridges and disposable devices, for high viscosity oil vapes. | Healthcare & Biotech | Portfolio page | ||
| Growlink provides a cultivation operating system for commercial growers | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
FintechHealthcare & Biotech | Portfolio page | |||
| LeafLink connects cannabis businesses, including brands, distributors, and retailers, on one platform for wholesale commerce | Climate & EnergyHealthcare & Biotech | Portfolio page | ||
| Mamedica prescribes and delivers medical cannabis to patients for various chronic conditions | Healthcare & Biotech | Sept 2025Round | Funding round | |
| Metrc provides a track-and-trace technology platform to track and trace cannabis from seed to sale | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| Miss Grass sells cannabis products, including THC gummies and other weed products, in several US states. | Healthcare & Biotech | Portfolio page | ||
| Pistil Data provides data-driven intelligence tools for the cannabis industry | Climate & EnergyHealthcare & Biotech | Portfolio page | ||
| The company develops and unites its own brands and companies in the areas of medical cannabis, research on cannabinoid-containing finished medicinal products, cosmetics, wellbeing, and lifestyle. | Healthcare & BiotechConsumer | Portfolio page | ||
| Surfside is the operating system for advertising and retail media, connecting brands, retailers, and shoppers across every channel | Media & EntertainmentE-commerce & Marketplaces | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page |
About this data
site last read 5 Nov 2026- Site
- casaverdecapital.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 1 Sept 2025
- Companies checked
- 20
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Casa Verde Capital's profile as data
Pull Casa Verde Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/casaverdecapital.com
# also
GET /v1/firms/casaverdecapital.com/portfolio
GET /v1/firms/casaverdecapital.com/coinvestors
GET /v1/firms/casaverdecapital.com/news